• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[氟苯达唑抑制A549和H460细胞增殖并促进自噬]

[Flubendazole Inhibits the Proliferation of A549 and H460 Cells and Promotes Autophagy].

作者信息

Dong Tingjun, Lu Zejun, Li Jingjiao, Liu Yongzhen, Wen Juyi

机构信息

The Second School of Clinical Medicine, Southern Medical University, Guangzhou 510280, China.

Tumor Diagnosis and Treatment Center, The Sixth Medical Center of PLA General Hospital, Beijing 100048, China.

出版信息

Zhongguo Fei Ai Za Zhi. 2020 May 20;23(5):306-313. doi: 10.3779/j.issn.1009-3419.2020.104.17.

DOI:10.3779/j.issn.1009-3419.2020.104.17
PMID:32429634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7260388/
Abstract

BACKGROUND

Flubendazole is an anthelmintic and categorized in benzimidazole. Previous evidence indicates its suppression on proliferation of colon cancer and breast cancer cells. Our study aims to explore the effects of flubendazole on non-small cell lung cancer A549 and H460 cell lines and the underlying mechanism.

METHODS

CCK-8 assay was used to detect the effect of flubendazole at different concentrations on viability of both cell lines A549 and H460. We used western blot to detect the expression levels of autophagy-related proteins p62 and LC3 after flubendazole treatment. Cells were transfected with tandem fluorescent adenovirus (mRFP-GFP-LC3), and the impact of flubendazole treatment on autophagic flux were analyzed.

RESULTS

Cell viability analysis showed a dose-dependent inhibitory effect on proliferation of both A549 and H460, comparing to cells without flubendazole treating (P<0.001). Level of p62 decreased and LC3 II/I ratio increased in cells treated with 2 μmol/L flubendazole for 24 h and 48 h, compared to control groups (P<0.005). Red fluorescence signals increased in mRFP-GFP-LC3 transfected cells after flubendazole treating, suggesting an elevation in autophagic flux.

CONCLUSIONS

Flubendazole may inhibit the proliferation of A549 and H460 cells and promote autophagy.

摘要

背景

氟苯达唑是一种抗蠕虫药,属于苯并咪唑类。先前的证据表明其对结肠癌细胞和乳腺癌细胞的增殖有抑制作用。我们的研究旨在探讨氟苯达唑对非小细胞肺癌A549和H460细胞系的影响及其潜在机制。

方法

采用CCK-8法检测不同浓度氟苯达唑对A549和H460两种细胞系活力的影响。我们使用蛋白质免疫印迹法检测氟苯达唑处理后自噬相关蛋白p62和LC3的表达水平。用串联荧光腺病毒(mRFP-GFP-LC3)转染细胞,并分析氟苯达唑处理对自噬流的影响。

结果

细胞活力分析显示,与未用氟苯达唑处理的细胞相比,氟苯达唑对A549和H460细胞的增殖均有剂量依赖性抑制作用(P<0.001)。与对照组相比,用2μmol/L氟苯达唑处理24小时和48小时的细胞中,p62水平降低,LC3 II/I比值升高(P<0.005)。氟苯达唑处理后,mRFP-GFP-LC3转染细胞中的红色荧光信号增加,表明自噬流升高。

结论

氟苯达唑可能抑制A549和H460细胞的增殖并促进自噬。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1a1/7260388/7f7ba08646c1/zgfazz-23-5-306-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1a1/7260388/55bbce218807/zgfazz-23-5-306-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1a1/7260388/60c890a218aa/zgfazz-23-5-306-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1a1/7260388/46ad692623b0/zgfazz-23-5-306-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1a1/7260388/7f7ba08646c1/zgfazz-23-5-306-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1a1/7260388/55bbce218807/zgfazz-23-5-306-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1a1/7260388/60c890a218aa/zgfazz-23-5-306-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1a1/7260388/46ad692623b0/zgfazz-23-5-306-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1a1/7260388/7f7ba08646c1/zgfazz-23-5-306-4.jpg

相似文献

1
[Flubendazole Inhibits the Proliferation of A549 and H460 Cells and Promotes Autophagy].[氟苯达唑抑制A549和H460细胞增殖并促进自噬]
Zhongguo Fei Ai Za Zhi. 2020 May 20;23(5):306-313. doi: 10.3779/j.issn.1009-3419.2020.104.17.
2
Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in Triple-negative Breast Cancer.氟苯达唑通过靶向 EVA1A 调节的自噬和凋亡在三阴性乳腺癌中发挥抗癌作用。
Theranostics. 2020 Jul 2;10(18):8080-8097. doi: 10.7150/thno.43473. eCollection 2020.
3
Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy.氟苯达唑通过抑制 STAT3 和激活自噬来发挥有效的抗肿瘤作用。
J Exp Clin Cancer Res. 2019 Jul 8;38(1):293. doi: 10.1186/s13046-019-1303-z.
4
A synthetic curcumin derivative hydrazinobenzoylcurcumin induces autophagy in A549 lung cancer cells.一种合成姜黄素衍生物肼基苯甲酰姜黄素可诱导A549肺癌细胞发生自噬。
Pharm Biol. 2014 Jan;52(1):111-6. doi: 10.3109/13880209.2013.816971. Epub 2013 Sep 18.
5
The anthelmintic flubendazole blocks human melanoma growth and metastasis and suppresses programmed cell death protein-1 and myeloid-derived suppressor cell accumulation.驱虫药氟苯达唑可抑制人黑色素瘤的生长和转移,并抑制程序性细胞死亡蛋白-1 和髓源抑制细胞的积累。
Cancer Lett. 2019 Sep 10;459:268-276. doi: 10.1016/j.canlet.2019.05.026. Epub 2019 May 23.
6
The induction of autophagy against mitochondria-mediated apoptosis in lung cancer cells by a ruthenium (II) imidazole complex.钌(II)咪唑配合物诱导肺癌细胞自噬以对抗线粒体介导的凋亡
Oncotarget. 2016 Dec 6;7(49):80716-80734. doi: 10.18632/oncotarget.13032.
7
Effects of MALAT1 on proliferation and apo- ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy.长链非编码 RNA MALAT1 通过调控自噬对人非小细胞肺癌 A549 细胞增殖和凋亡及体内移植瘤生长的影响
Cancer Biomark. 2018;22(1):63-72. doi: 10.3233/CBM-170917.
8
Systems biology-based discovery of a potential Atg4B agonist (Flubendazole) that induces autophagy in breast cancer.基于系统生物学发现一种潜在的Atg4B激动剂(氟苯达唑),其可在乳腺癌中诱导自噬。
Mol Biosyst. 2015 Nov;11(11):2860-6. doi: 10.1039/c5mb00466g.
9
Flubendazole Plays an Important Anti-Tumor Role in Different Types of Cancers.氟苯达唑在不同类型癌症中发挥重要的抗肿瘤作用。
Int J Mol Sci. 2022 Jan 4;23(1):519. doi: 10.3390/ijms23010519.
10
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.氟苯达唑是一种经美国食品药品监督管理局批准的驱虫药,可靶向乳腺癌干细胞样细胞。
Oncotarget. 2015 Mar 20;6(8):6326-40. doi: 10.18632/oncotarget.3436.

引用本文的文献

1
Flubendazole Plays an Important Anti-Tumor Role in Different Types of Cancers.氟苯达唑在不同类型癌症中发挥重要的抗肿瘤作用。
Int J Mol Sci. 2022 Jan 4;23(1):519. doi: 10.3390/ijms23010519.
2
Repositioning of Antiparasitic Drugs for Tumor Treatment.抗寄生虫药物重新定位用于肿瘤治疗
Front Oncol. 2021 Apr 29;11:670804. doi: 10.3389/fonc.2021.670804. eCollection 2021.

本文引用的文献

1
Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy.氟苯达唑通过抑制 STAT3 和激活自噬来发挥有效的抗肿瘤作用。
J Exp Clin Cancer Res. 2019 Jul 8;38(1):293. doi: 10.1186/s13046-019-1303-z.
2
The anthelmintic flubendazole blocks human melanoma growth and metastasis and suppresses programmed cell death protein-1 and myeloid-derived suppressor cell accumulation.驱虫药氟苯达唑可抑制人黑色素瘤的生长和转移,并抑制程序性细胞死亡蛋白-1 和髓源抑制细胞的积累。
Cancer Lett. 2019 Sep 10;459:268-276. doi: 10.1016/j.canlet.2019.05.026. Epub 2019 May 23.
3
The anthelmintic drug flubendazole induces cell apoptosis and inhibits NF-κB signaling in esophageal squamous cell carcinoma.
抗蠕虫药氟苯达唑可诱导食管鳞状细胞癌细胞凋亡并抑制核因子κB信号通路。
Onco Targets Ther. 2019 Jan 9;12:471-478. doi: 10.2147/OTT.S193206. eCollection 2019.
4
Flubendazole as a macrofilaricide: History and background.氟苯达唑作为一种杀微丝蚴药物:历史与背景。
PLoS Negl Trop Dis. 2019 Jan 16;13(1):e0006436. doi: 10.1371/journal.pntd.0006436. eCollection 2019 Jan.
5
Flubendazole inhibits glioma proliferation by G2/M cell cycle arrest and pro-apoptosis.氟苯达唑通过G2/M期细胞周期阻滞和促凋亡作用抑制胶质瘤增殖。
Cell Death Discov. 2018 Feb 14;4:18. doi: 10.1038/s41420-017-0017-2. eCollection 2018 Dec.
6
The biology and management of non-small cell lung cancer.非小细胞肺癌的生物学特性与治疗管理。
Nature. 2018 Jan 24;553(7689):446-454. doi: 10.1038/nature25183.
7
Flubendazole overcomes trastuzumab resistance by targeting cancer stem-like properties and HER2 signaling in HER2-positive breast cancer.氟苯达唑通过靶向 HER2 阳性乳腺癌中的癌症干细胞样特性和 HER2 信号转导克服曲妥珠单抗耐药性。
Cancer Lett. 2018 Jan 1;412:118-130. doi: 10.1016/j.canlet.2017.10.020. Epub 2017 Nov 5.
8
Anthelmintic Flubendazole and Its Potential Use in Anticancer Therapy.抗蠕虫药氟苯达唑及其在抗癌治疗中的潜在用途。
Acta Medica (Hradec Kralove). 2017;60(1):5-11. doi: 10.14712/18059694.2017.44. Epub 2017 Apr 11.
9
Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer.自噬与凋亡在非小细胞肺癌中的作用
Int J Mol Sci. 2017 Feb 10;18(2):367. doi: 10.3390/ijms18020367.
10
Research progress of hydroxychloroquine and autophagy inhibitors on cancer.羟氯喹啉与自噬抑制剂在癌症方面的研究进展
Cancer Chemother Pharmacol. 2017 Feb;79(2):287-294. doi: 10.1007/s00280-016-3197-1. Epub 2016 Nov 26.